 |
Alexander Sulakvelidze, PhD Dr. Alexander “Sandro”
Sulakvelidze, Ph.D., is Chief Scientist of Intralytix, and an
internationally recognized expert in phage technology and
infectious disease epidemiology. Dr. Sulakvelidze has served/is
serving as the Principal Investigator/Project Director of
several grants and contracts from various agencies and
foundations, including the National Institutes of Health (NIH),
United States Department of Defense (DOD), United States
Environmental Protection Agency (EPA), United States Department
of Agriculture (USDA), National Food Processors Association (NFPA),
Department of Health and Human Services Biotechnology Engagement
Program (BTEP), and the Civilian Research and Development
Foundation (CRDF).
Dr. Sulakvelidze has published extensively on
the subjects of phage therapy, and he is the author of several
issued and pending patents related to the field. He also
co-edited (with Dr. Elizabeth Kutter) a major book about
bacteriophages (for which he also wrote two main chapters
related to the use of bacteriophages in agricultural and human
therapeutic settings), which was published by the CRC Press in
2005. His phage therapy research has been featured in several
magazines and newspapers (including the Los Angeles Times,
Newsweek, Science, Smithsonian and Wired), and in various radio
programs and television documentaries (including National Public
Radio’s Science Friday, BBC Radio and Voice of America radio
programs, and BBC Horizon documentary about phage therapy).
Dr.
Sulakvelidze serves as an ad hoc reviewer for various journals,
such as Antimicrobial Agents and Chemotherapy, Applied and
Environmental Microbiology, FEMS Immunology and Medical
Microbiology, Clinical and Experimental Dermatology, Food
Microbiology, and Journal of Clinical Microbiology, and for
several funding agencies, including the CRDF, the International
Science and Technology Center (ISTC), the United States-Israel Bi-national
Science Foundation (BSF), and the NIH.
|
|
